Literature DB >> 816150

Autologous marrow reconstitutions in severe aplastic anaemia after ALG pretreatment and HL-A semi-incompatible bone marrow cell transfusion.

M Jeannet, B Speck, A Rubinstein, B Pelet, M Wyss, H Kummer.   

Abstract

Three consecutive patients considered to have end-stage acquired aplastic anaemia were given 100-160 mg/kg antilymphocyte globulin (ALG) i.v. followed by an infusion of 2-3.8 x 10(8) nucleated marrow cells/kg i.v. from HL-A one haplotype-identical, MLC-positive family donors. All patients showed autologous marrow reconstitutions lasting now 2-3 1/2 years. No clear-cut evidence of marrow engraftment could be established and no graft-versus-host disease was seen. It is assumed that these patients had some normal pluripotent haemopoetic stem cells which proved to be able of endoreduplication and of going into cycle after ALG conditioning and allogeneic marrow transfusion.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 816150     DOI: 10.1159/000208005

Source DB:  PubMed          Journal:  Acta Haematol        ISSN: 0001-5792            Impact factor:   2.195


  4 in total

1.  Inhibitory effects of peripheral blood cells on in vitro colony formation by autologous bone marrow in aplastic anaemia: relation with response to immunosuppressive therapy.

Authors:  A Blasetti; A Faille; N Balitrand; E Gluckman; A Devergie; C Dresch
Journal:  J Clin Pathol       Date:  1982-12       Impact factor: 3.411

Review 2.  Immunosuppressive treatment of acquired aplastic anemia and immune-mediated bone marrow failure syndromes.

Authors:  Neal S Young
Journal:  Int J Hematol       Date:  2002-02       Impact factor: 2.490

3.  Effect of T-lymphocytes on normal haemopoiesis: studies in congenitally athymic nude mice.

Authors:  G Harris; S N Wickramasinghe
Journal:  Blut       Date:  1979-09

4.  Reversal of aplastic anaemia secondary to systemic lupus erythematosus by high-dose intravenous cyclophosphamide.

Authors:  M J Walport; W N Hubbard; G R Hughes
Journal:  Br Med J (Clin Res Ed)       Date:  1982-09-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.